ASX/AFP (ASX/AFP)

Australian Securities Exchange: ASX/AFP · AUD

A$3.72

+0.00 (0.0%)· Recorded snapshot

Market cap	393.7M
Revenue (ttm)	212.1M
Net income (ttm)	12.3M
EPS (ttm)	A$0.11
P/E (trailing)	33.3x
P/E (forward)	24.7x
Dividend	A$0.02 (0.65%)
Volume	27
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 212.1M
Net income (ttm): 12.3M
EPS (ttm): A$0.11
P/E (trailing): 33.3x
P/E (forward): 24.7x
Market cap: 393.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E24.7

P25 n/aP50 n/aP75 n/a

Trailing P/E33.3

P25 n/aP50 n/aP75 n/a

ROE13.7

P25 n/aP50 n/aP75 n/a

ROIC10.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/AFP indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

NZD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	New Zealand
Country code	AU
Earnings date	2026-11-19
Employees	126
Employees change	9
Employees growth	8.18%
Enterprise value	AUD 428.2M
Exchange	Australian Securities Exchange
Financial currency	NZD
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	March
Founded	1997
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	NZAFTE0001S4
Last earnings date	2026-05-20
Last refreshed	2026-10-28
Market cap	AUD 393.7M
Next earnings date	2026-11-19
Price	AUD 3.72
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-26
Symbol	asx/AFP
Website	https://www.aftpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	39.98x
Average P/E ratio (3Y)	25.11x
Average P/E ratio (5Y)	27.35x
Earnings yield	3%
EV/Earnings	34.92x
EV/EBIT	21.65x
EV/EBITDA	20.56x
EV/Sales	2.08x
FCF / EV yield	-1.88%
FCF yield	-2.04%
Forward P/E	24.71x
Graham number	1.49562
Graham upside	-59.8%
Lynch fair value	AUD 1.64
Lynch upside	-55.87%
P/B ratio	4.34x
P/E ratio	33.31x
P/S ratio	1.86x
Price / tangible book value	5.1x
Price/EBITDA ratio	19.02x
Sector forward P/E	34.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.6%
EBITDA margin	9.76%
Effective tax rate	35.64%
Gross margin	43.4%
Operating margin	9.6%
Pretax margin	8.59%
Profit margin	5.78%
Profit per employee	AUD 97,331
Profitable quarters	3
Profitable years	7
Revenue per employee	AUD 1.7M
ROA	7.9%
ROA (5Y)	8.81%
ROCE	16.22%
ROE	13.66%
ROE (5Y)	20.25%
ROIC	10.29%
ROIC (5Y)	15.2%
SBC / revenue	0.02%
Tax / revenue	3.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	27.27%
EPS growth (Q)	-16.51%
EPS growth (QoQ)	280.2%
EPS growth 3Y	11.27%
EPS growth 5Y	14.63%
EPS growth years	1
Gross profit growth	20.54%
Gross profit growth (Q)	9.63%
Gross profit growth 3Y	14.85%
Gross profit growth 5Y	17.8%
Net income growth	23.14%
Net income growth (Q)	-19.2%
Net income growth (QoQ)	246.63%
Net income growth 3Y	11.4%
Net income growth 5Y	14.17%
Net income growth years	1
Operating income growth	38.51%
Operating income growth (Q)	1.32%
Operating income growth 3Y	7.52%
Operating income growth 5Y	17.95%
Revenue growth	22.44%
Revenue growth (Q)	15.21%
Revenue growth (QoQ)	21.59%
Revenue growth 10Y	14.81%
Revenue growth 3Y	17.59%
Revenue growth 5Y	17.63%
Revenue growth quarters	22
Revenue growth years	13

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -96,577
Depreciation and amortization	AUD 337,452
EBIT	AUD 20.4M
EBITDA	AUD 20.7M
EPS	AUD 0.11
Financing cash flow	AUD 7.3M
Free cash flow	AUD -8M
Free cash flow minus SBC	AUD -8.1M
Gross profit	AUD 92M
Income taxes	AUD 6.5M
Investing cash flow	AUD -8.1M
Net borrowing	AUD 10.5M
Net cash flow	AUD -9M
Net income	AUD 12.3M
Operating cash flow minus SBC	AUD -8M
Operating income	AUD 20.4M
Revenue	AUD 212.1M
Stock-based compensation	AUD 43,293

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.99
Book value per share	AUD 0.88
Debt / EBITDA	2.1
Debt / equity	0.5
Interest coverage	9.83
Long-term assets	AUD 62.2M
Long-term liabilities	AUD 36.9M
Net cash (debt)	AUD -36.5M
Net cash / market cap	-9.28%
Net debt / EBITDA	1.76
Net debt / equity	0.4
Piotroski F-Score	3
Property, plant and equipment	AUD 2.7M
Shareholders' equity	AUD 90.8M
Tangible book value	AUD 77.2M
Tangible book value per share	AUD 0.74
Total assets	AUD 180.7M
Total cash	AUD 8.5M
Total debt	AUD 45M
Total liabilities	AUD 89.9M
WACC	6.41%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.32
Current assets	AUD 118.5M
Current liabilities	AUD 52.9M
Current ratio	2.24
Inventory turnover	2.35
Net working capital	AUD 70.3M
Quick ratio	1.03
Working capital	AUD 68.4M
Working capital turnover	2.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	44.15%
Dividend growth years	2
Dividend payment date	2026-07-03
Dividend payment years	4
Dividend payout frequency	Annual
Dividend per share	AUD 0.02
Dividend yield	0.65%
Ex-dividend date	2026-06-18
Last dividend	AUD 0.02
Payout ratio	12.81%
Shareholder yield	0.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	28.28%
10Y return CAGR	2.76%
10Y total return	31.27%
150-day SMA	AUD 3.26
1D price change	0%
1M price change	6.9%
1M total return	6.9%
1W price change	2.48%
1W total return	2.48%
1Y price change	42.53%
1Y return CAGR	43.7%
1Y total return	43.66%
20-day SMA	AUD 3.56
200-day SMA	AUD 3.07
3M price change	-0.8%
3M total return	-0.8%
3Y price change	16.25%
3Y return CAGR	5.85%
3Y total return	18.61%
50-day SMA	AUD 3.66
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 4.13
52-week high date	2026-07-31
52-week low	AUD 2.64
52-week low date	2025-11-03
5Y price change	-4.62%
5Y return CAGR	-0.48%
5Y total return	-2.39%
6M price change	18.1%
6M total return	19.04%
All-time high	AUD 5.25
All-time high date	2020-11-10
All-time low	AUD 1.90
All-time low date	2019-04-24
Average true range (ATR)	AUD 0.06
Average volume	2.3K
Beta (5Y)	0.47
Change from 52-week high	-9.93%
Change from 52-week low	40.91%
Change from all-time high	-29.14%
Change from all-time low	95.79%
Change from open	1.64%
Day's gap	-1.61%
Dollar volume	AUD 100
High price	AUD 3.72
Low price	AUD 3.66
Monthly RSI	58.85
Open price	AUD 3.66
Position in 52-week range	100%
Previous close	AUD 3.72
Price vs 150-day SMA	14.11%
Price vs 20-day SMA	4.44%
Price vs 200-day SMA	21.25%
Price vs 50-day SMA	1.78%
Relative volume	0.01
RSI	59.31
Sharpe ratio	0.99
Sharpe ratio (3Y)	0.12
Sortino ratio	1.69
Sortino ratio (3Y)	0.3
Volume	27
Weekly RSI	58.84
YTD price change	24%
YTD total return	24.99%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30.4M
Shares change (QoQ)	-9.22%
Shares held by insiders	69.38%
Shares held by institutions	8.05%

Deeper analysis on ASX/AFP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/AFP report

Is a complete ASX/AFP research report available?

No complete published report is available for asx/AFP (ASX/AFP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/AFP (ASX/AFP)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/AFP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/AFP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/AFP

Frequently asked questions